aTyr Pharma Inc (LIFE)
1.60
-0.02
(-1.23%)
USD |
NASDAQ |
Apr 24, 16:00
1.60
0.00 (0.00%)
After-Hours: 20:00
aTyr Pharma Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -3.21K% |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | -72.41% |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 |
| Date | Value |
|---|---|
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -240.2% |
| September 30, 2020 | -4.46K% |
| June 30, 2020 | -3.41K% |
| March 31, 2020 | 21.74% |
| December 31, 2019 | -4.15K% |
| September 30, 2019 | -3.07K% |
| June 30, 2019 | -6.22K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-6.22K%
Minimum
Jun 2019
21.74%
Maximum
Mar 2020
-2.76K%
Average
-3.21K%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
| Vaxart Inc | -262.3% |
| Allogene Therapeutics Inc | -- |
| AIM ImmunoTech Inc | -19.35K% |
| Protalix BioTherapeutics Inc | -57.64% |
| Armata Pharmaceuticals Inc | -- |